MA26945A1 - Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine. - Google Patents

Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.

Info

Publication number: MA26945A1
Authority: MA; Morocco
Prior art keywords: phenoxybenzylamine; derivatives; novel; selective serotonin; reabsorption inhibitors
Prior art date: 2000-08-31

Application number

MA27049A

Other languages

English (en)

French (fr)

Inventor

Mavis Diane Adam

Mark David Andrews

Mark Leonard Elliott

Geoffrey Edward Gymer

David Hepworth

Harry Ralph Howard Jr

Donald Stuart Middleton

Alan Stobie

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-31

Filing date

2003-02-21

Publication date

2004-12-20

2000-08-31 Priority claimed from GB0021593A external-priority patent/GB0021593D0/en

2001-03-21 Priority claimed from GB0107116A external-priority patent/GB0107116D0/en

2003-02-21 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26945A1 publication Critical patent/MA26945A1/fr

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
239000003112 inhibitor Substances 0.000 title 1
YXMXAXHPRPWBJB-UHFFFAOYSA-N n-phenoxy-1-phenylmethanamine Chemical class C=1C=CC=CC=1CNOC1=CC=CC=C1 YXMXAXHPRPWBJB-UHFFFAOYSA-N 0.000 title 1
230000009103 reabsorption Effects 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Addiction (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Quinoline Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MA27049A 2000-08-31 2003-02-21 Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine. MA26945A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0021593A GB0021593D0 (en)	2000-08-31	2000-08-31	Diphenyl ether compounds useful in therapy
GB0107116A GB0107116D0 (en)	2001-03-21	2001-03-21	Novel compounds

Publications (1)

Publication Number	Publication Date
MA26945A1 true MA26945A1 (fr)	2004-12-20

Family

ID=26244953

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27049A MA26945A1 (fr)	2000-08-31	2003-02-21	Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.

Country Status (32)

Country	Link
EP (1)	EP1313701A1 (es)
JP (1)	JP2004507523A (es)
KR (1)	KR20030029889A (es)
CN (1)	CN1449380A (es)
AP (1)	AP2001002265A0 (es)
AR (1)	AR031867A1 (es)
AU (1)	AU2001278650A1 (es)
BG (1)	BG107544A (es)
BR (1)	BR0113610A (es)
CA (1)	CA2420969A1 (es)
CZ (1)	CZ2003467A3 (es)
DO (1)	DOP2001000242A (es)
DZ (1)	DZ3414A1 (es)
EA (1)	EA200300206A1 (es)
EE (1)	EE200300084A (es)
HN (1)	HN2001000191A (es)
HR (1)	HRP20030141A2 (es)
HU (1)	HUP0303385A2 (es)
IL (1)	IL154343A0 (es)
IS (1)	IS6704A (es)
MA (1)	MA26945A1 (es)
MX (1)	MXPA03001848A (es)
NO (1)	NO20030842L (es)
NZ (1)	NZ523951A (es)
OA (1)	OA12372A (es)
PA (1)	PA8526701A1 (es)
PE (1)	PE20020346A1 (es)
PL (1)	PL360743A1 (es)
SK (1)	SK2012003A3 (es)
TN (1)	TNSN01131A1 (es)
UY (1)	UY26924A1 (es)
WO (1)	WO2002018333A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403597B1 (en) *	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6436938B1 (en) *	2001-01-22	2002-08-20	Pfizer Inc.	Combination treatment for depression
US20020107244A1 (en) *	2001-02-02	2002-08-08	Howard Harry R.	Combination treatment for depression
US20020183306A1 (en) *	2001-05-30	2002-12-05	Pfizer Inc.	Combination treatment for sleep disorders including sleep apnea
GB0318706D0 (en) *	2003-08-08	2003-09-10	Pfizer Ltd	Selective serotonin reuptake inhibitors in the treatment of disease
CA2554696C (en)	2004-02-13	2009-06-30	Warner-Lambert Company Llc	Androgen receptor modulators
EP1737813A1 (en)	2004-04-13	2007-01-03	Warner-Lambert Company LLC	Androgen modulators
WO2005102990A1 (en)	2004-04-22	2005-11-03	Warner-Lambert Company Llc	Androgen modulators
CA2570047C (en)	2004-07-08	2010-09-28	Warner-Lambert Company Llc	4-cycloalkoxy benzonitriles as androgen modulators
US20090105349A1 (en) *	2004-08-18	2009-04-23	Warner-Lambert Company Llc	Androgen modulators
CA2580024A1 (en) *	2004-09-10	2006-03-16	Pfizer Products Inc.	Therapeutic diphenyl ether ligands
TW200724139A (en)	2005-05-05	2007-07-01	Warner Lambert Co	Androgen modulators
WO2007010350A1 (en) *	2005-07-19	2007-01-25	Pfizer Products Inc.	Synthesis of therapeutic diphenyl ethers
WO2007047397A2 (en)	2005-10-13	2007-04-26	Smithkline Beecham Corporation	Phenol ethers as modulators of the opioid receptors
EP1976495A2 (en) *	2006-01-06	2008-10-08	Aarhus Universitet	Compounds acting on the serotonin transporter
US7767666B2 (en)	2006-06-29	2010-08-03	Janssen Pharmaceutica Nv	Butyl and butynyl benzyl amine compounds
JP2009544579A (ja)	2006-06-29	2009-12-17	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	置換ベンジルアミン化合物
EP2046747A1 (en) *	2006-06-29	2009-04-15	Janssen Pharmaceutica N.V.	Substituted aminomethyl benzamide compounds
WO2010059390A1 (en)	2008-10-30	2010-05-27	Janssen Pharmaceutica Nv	Modulators of serotonin receptor
US8642583B2 (en)	2008-10-30	2014-02-04	Janssen Pharmaceutica Nv	Serotonin receptor modulators
KR101043200B1 (ko) *	2010-11-08	2011-06-21	성시민	호흡용 공기탱크의 공기 충전장치
DE112011104795T5 (de)	2011-01-27	2013-10-31	Hewlett-Packard Development Company, L.P.	Computer-Vorrichtung zur Verbindung an eine tragbare Vorrichtung
KR20210135521A (ko)	2019-03-06	2021-11-15	다이이찌 산쿄 가부시키가이샤	피롤로피라졸 유도체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA923283B (en) *	1991-05-29	1993-01-27	Akzo Nv	Phenoxyphenyl derivatives
NZ271833A (en) *	1993-08-19	1997-08-22	Warner Lambert Co	Substituted 2(5h)-furanone (or thiophenone or pyrrolone) derivatives
CZ293595A3 (cs) *	1995-11-09	1999-12-15	Farmak A. S.	Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
EP1071648A2 (en) *	1998-03-13	2001-01-31	Merck Frosst Canada & Co.	Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
EE200100441A (et) *	1999-02-23	2002-12-16	Pfizer Products Inc.	Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
GB0007884D0 (en) *	2000-03-31	2000-05-17	Pfizer Ltd	Diphenyl ether compounds useful in therapy

2001
- 2001-08-22 OA OA1200300056A patent/OA12372A/en unknown
- 2001-08-22 CN CN01814846A patent/CN1449380A/zh active Pending
- 2001-08-22 EA EA200300206A patent/EA200300206A1/ru unknown
- 2001-08-22 DZ DZ013414A patent/DZ3414A1/fr active
- 2001-08-22 CA CA002420969A patent/CA2420969A1/en not_active Abandoned
- 2001-08-22 IL IL15434301A patent/IL154343A0/xx unknown
- 2001-08-22 HR HR20030141A patent/HRP20030141A2/hr not_active Application Discontinuation
- 2001-08-22 PL PL36074301A patent/PL360743A1/xx not_active Application Discontinuation
- 2001-08-22 EE EEP200300084A patent/EE200300084A/xx unknown
- 2001-08-22 SK SK201-2003A patent/SK2012003A3/sk unknown
- 2001-08-22 KR KR10-2003-7003011A patent/KR20030029889A/ko not_active Ceased
- 2001-08-22 NZ NZ523951A patent/NZ523951A/en unknown
- 2001-08-22 CZ CZ2003467A patent/CZ2003467A3/cs unknown
- 2001-08-22 EP EP01956734A patent/EP1313701A1/en not_active Withdrawn
- 2001-08-22 WO PCT/IB2001/001521 patent/WO2002018333A1/en not_active Ceased
- 2001-08-22 BR BR0113610-0A patent/BR0113610A/pt not_active IP Right Cessation
- 2001-08-22 MX MXPA03001848A patent/MXPA03001848A/es active IP Right Grant
- 2001-08-22 JP JP2002523451A patent/JP2004507523A/ja active Pending
- 2001-08-22 HU HU0303385A patent/HUP0303385A2/hu unknown
- 2001-08-22 AP APAP/P/2001/002265A patent/AP2001002265A0/en unknown
- 2001-08-22 AU AU2001278650A patent/AU2001278650A1/en not_active Abandoned
- 2001-08-24 PA PA20018526701A patent/PA8526701A1/es unknown
- 2001-08-28 HN HN2001000191A patent/HN2001000191A/es unknown
- 2001-08-28 PE PE2001000862A patent/PE20020346A1/es not_active Application Discontinuation
- 2001-08-29 DO DO2001000242A patent/DOP2001000242A/es unknown
- 2001-08-29 AR ARP010104114A patent/AR031867A1/es unknown
- 2001-08-30 TN TNTNSN01131A patent/TNSN01131A1/fr unknown
- 2001-08-31 UY UY26924A patent/UY26924A1/es not_active Application Discontinuation
2003
- 2003-01-30 IS IS6704A patent/IS6704A/is unknown
- 2003-02-07 BG BG107544A patent/BG107544A/bg unknown
- 2003-02-21 MA MA27049A patent/MA26945A1/fr unknown
- 2003-02-24 NO NO20030842A patent/NO20030842L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DOP2001000242A (es)	2002-05-15
NZ523951A (en)	2004-09-24
AU2001278650A1 (en)	2002-03-13
PL360743A1 (en)	2004-09-20
DZ3414A1 (fr)	2002-03-07
CA2420969A1 (en)	2002-03-07
TNSN01131A1 (fr)	2005-11-10
EP1313701A1 (en)	2003-05-28
AR031867A1 (es)	2003-10-08
HUP0303385A2 (hu)	2004-03-01
PE20020346A1 (es)	2002-05-08
WO2002018333A1 (en)	2002-03-07
EE200300084A (et)	2005-02-15
MXPA03001848A (es)	2003-06-04
EA200300206A1 (ru)	2003-06-26
IL154343A0 (en)	2003-09-17
IS6704A (is)	2003-01-30
AP2001002265A0 (en)	2001-09-30
NO20030842D0 (no)	2003-02-24
KR20030029889A (ko)	2003-04-16
CN1449380A (zh)	2003-10-15
PA8526701A1 (es)	2003-07-28
HRP20030141A2 (en)	2003-04-30
HN2001000191A (es)	2002-03-11
BR0113610A (pt)	2003-06-24
NO20030842L (no)	2003-04-28
SK2012003A3 (en)	2004-06-08
JP2004507523A (ja)	2004-03-11
OA12372A (en)	2006-04-17
UY26924A1 (es)	2002-03-22
BG107544A (bg)	2003-10-31
CZ2003467A3 (cs)	2004-04-14

Publication	Publication Date	Title
FR12C0007I2 (fr)	2012-10-26	Nouveaux derives de phenyle-propargylether
MA26060A1 (fr)	2004-04-01	Nouveaux derives de pyrazolopyridine
MA26887A1 (fr)	2004-12-20	Derives de piperazine nouveaux.
DE60216115D1 (de)	2006-12-28	BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
MXPA03008807A (es)	2004-02-12	Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
EG25095A (en)	2011-08-17	Phenyl-piperazines derivatives as serotonin reuptake inhibitors.
DE60019577D1 (de)	2005-05-25	4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DE60135046D1 (de)	2008-09-04	Luftbeförderter Wasserverteiler
MA26932A1 (fr)	2004-12-20	Derives d'imidazole.
DZ3439A1 (fr)	2001-12-13	Derives de 2-aminocarbonyl-9h-purine
DE60214428D1 (de)	2006-10-12	1, 4-dihydro-1, 4-diphenylpyridin-derivate
DZ3414A1 (fr)	2002-03-07	Derives de la phenoxybenzylamine inhibiteurs selectifs du recaptage de la serotonine
MA26848A1 (fr)	2004-12-20	Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
FR2838123B1 (fr)	2005-06-10	Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
IT1320509B1 (it)	2003-12-10	Faro per motociclo.
NO20032142D0 (no)	2003-05-13	Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister
DE50107988D1 (de)	2005-12-15	Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
FR2810318B1 (fr)	2005-09-23	Derives de diamano-phenothiazine
AR028248A1 (es)	2003-04-30	Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
DZ3119A1 (fr)	2004-09-19	Nouveaux dérivés de n-triazolylmethyl-piperazines comme antagonistes des recepteurs de la neurokinine.
AR028607A1 (es)	2003-05-14	Derivados de 1,4-diazepan-2,5-diona
MA26941A1 (fr)	2004-12-20	Nouveaux derives d'aminocyclohexane
FR2824826B1 (fr)	2003-11-07	Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
NO20042980L (no)	2004-07-14	3,4-dihydro-1H-isokinolin-2-yl-derivater
MA26797A1 (fr)	2004-12-20	Nouveaux inhibiteurs selectifs de sous-types recepteurs de nmda.